Dimethylformamide diethylacetal → 3-(Dimethylamino)-2-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]acrylic acid methyl ester
반응식
[CH2:1]([O:3][C:4](=[O:15])[CH2:5][C:6]1[S:7][C:8]([C:11]([F:14])([F:13])[F:12])=[N:9][N:10]=1)C.C(O[CH:19](OCC)[N:20]([CH3:22])[CH3:21])C>>[CH3:1][O:3][C:4](=[O:15])[C:5]([C:6]1[S:7][C:8]([C:11]([F:14])([F:13])[F:12])=[N:9][N:10]=1)=[CH:19][N:20]([CH3:22])[CH3:21]참가 물질
3
실험 절차
3.05 g (13.5 mmol) 5-(trifluoromethyl)-1,3,4-thiadiazol-2-ylacetic acid ethyl ester [for preparation see DE 42 40 168-A1] are heated in 6.9 ml (40.5 mmol) dimethylformamide diethyl acetal overnight at 100° C. After cooling, the mixture is concentrated and the residue is purified by means of preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient).
후처리
- temperatureAfter cooling
- concentrationthe mixture is concentrated
- customthe residue is purified by means of preparative HPLC (RP18 column; mobile phase: acetonitrile/water gradient)
출처 및 근거
- ORD 기록
- ord-07dd5932190f4f0087ae7f4892ccfbf9
- 출처 데이터셋
- uspto-grants-2014_02
- 특허 번호
- US08653111B2
반응 노트
불러오는 중…